TSHR and Graves disease: The term ‘receptor autoimmunity’ was coined by Duncan D. Adams, a New Zealand endocrinologist, who in the mid-1950s-highlighted the pathogenic role of autoantibodies against the TSH receptor (TSHR), at the time known as LATS (long-acting thyroid stimulator), in autoimmune hyperthyroidism or Graves’ disease (GD) [1, 2].